| 000 | 01002 a2200265 4500 | ||
|---|---|---|---|
| 005 | 20250515093206.0 | ||
| 264 | 0 | _c20080123 | |
| 008 | 200801s 0 0 fre d | ||
| 022 | _a0003-4509 | ||
| 024 | 7 |
_a10.1016/s0003-4509(07)92597-3 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aVillart, M | |
| 245 | 0 | 0 |
_a[Botulinum toxin and the hospital pharmacy]. _h[electronic resource] |
| 260 |
_bAnnales pharmaceutiques francaises _cSep 2007 |
||
| 300 |
_a342-6 p. _bdigital |
||
| 500 | _aPublication Type: English Abstract; Journal Article; Review | ||
| 650 | 0 | 4 |
_aAnti-Dyskinesia Agents _xtherapeutic use |
| 650 | 0 | 4 |
_aBotulinum Toxins _xtherapeutic use |
| 650 | 0 | 4 |
_aBotulinum Toxins, Type A _xtherapeutic use |
| 650 | 0 | 4 | _aDrug Prescriptions |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aMuscle Spasticity _xdrug therapy |
| 773 | 0 |
_tAnnales pharmaceutiques francaises _gvol. 65 _gno. 5 _gp. 342-6 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/s0003-4509(07)92597-3 _zAvailable from publisher's website |
| 999 |
_c17500454 _d17500454 |
||